GeraClinic / NHS cancer waiting times / Methodology
Gera Cancer Pathway Pressure Index — Methodology
Open, reproducible methodology for the Gera Cancer Pathway Pressure Index (GCPPI) — computed from real NHS England data, updated monthly.
Data source
- Reference period
- April 2026
- Published
- June 2026
- Publisher
- NHS England
- Licence
- Open Government Licence v3.0
- ICB mapping
- NHS Organisation Data Service (ODS), spineservices.nhs.uk
Index formula
Raw pressure = (1 − pct_62day_met / 100) × referral_volume
GCPPI = (raw_pressure − min_raw) / (max_raw − min_raw) × 100
Where:
- pct_62day_met: percentage of patients starting treatment within 62 days of urgent referral (62-day Combined standard, summed across all sub-pathways per ICB). NHS target: 85%.
- referral_volume: total 28-day Faster Diagnosis Standard (FDS) referrals per ICB — the most upstream, highest-volume measure of cancer pathway demand.
- min_raw / max_raw: the minimum and maximum raw pressure values across all 36 ICBs in the April 2026 dataset, used to normalise the index to 0–100.
England baseline (April 2026)
62-day standard (England)
69.8%
NHS target: 85%
28-day FDS (England)
75.9%
NHS target: 75%
Patients in 62-day pathway
27,522
FDS referrals: 268,574
Step-by-step computation
- 1
Obtain NHS England CWT data
Download the monthly ICB Sub-Location data extract from the NHS England Cancer Waiting Times statistics page (https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/). The file contains columns: PERIOD, YEAR, MONTH, STANDARD, ICB SUB LOCATION (code), SUB-CATEGORY, TOTAL, WITHIN STANDARD, BREACHES.
- 2
Map sub-location codes to parent ICBs
The extract uses ONS ICB sub-location codes (e.g. 00L, 00T). Map each code to its parent Integrated Care Board using the NHS Organisation Data Service (ODS) API (directory.spineservices.nhs.uk), filtering for PrimaryRoleId=RO98 (CLINICAL COMMISSIONING GROUP). Each code's "Name" field embeds the parent ICB.
- 3
Sum 62-day Combined rows per parent ICB
Filter to rows where STANDARD = "62-day Combined". For each parent ICB, sum TOTAL across all sub-locations (total62) and sum WITHIN STANDARD (within62). Compute pct62 = within62 / total62 × 100. This aggregates all four 62-day sub-pathways: Urgent Suspected Cancer, Screening, Consultant Upgrade, and Breast Symptomatic.
- 4
Sum 28-day FDS rows per parent ICB for referral volume
Filter to rows where STANDARD = "28-day FDS". For each parent ICB, sum TOTAL across all sub-locations (refVol). This is the Faster Diagnosis Standard referral volume — the most upstream measure of cancer pathway demand. Also compute pct28 = FDS within-standard / refVol × 100.
- 5
Compute raw pathway pressure
For each ICB: raw_pressure = (1 − pct62 / 100) × refVol. This captures both the magnitude of 62-day target failure and the volume of patients affected. An ICB that misses the target by 30 percentage points with 10,000 referrals has higher raw pressure than one that misses by 30 pp with 1,000 referrals.
- 6
Normalise to 0–100 (GCPPI)
gcppi = (raw_pressure − min_raw) / (max_raw − min_raw) × 100, rounded to one decimal place. The ICB with the lowest raw pressure scores 0; the ICB with the highest raw pressure scores 100. All other ICBs are linearly interpolated between these bounds. The index is re-computed monthly when new NHS England data is published.
NHS cancer standards context
62-day standard: At least 85% of patients urgently referred for suspected cancer should start first definitive treatment within 62 days of receipt of referral.
28-day Faster Diagnosis Standard (FDS): At least 75% of patients referred on a 2-week-wait pathway should receive a definitive diagnosis — cancer or a ruling out — within 28 days of referral.
Both standards are set by NHS England. The GCPPI uses the 62-day standard as its primary performance measure because it encompasses the full treatment-decision pathway and is the headline accountability metric.
Caveats and limitations
- The GCPPI is a relative index: it ranks ICBs within theApril 2026 cohort. The raw pressure values and therefore the normalised index will change each month as new data is published.
- Sub-location codes in the CWT extract are mapped to parent ICBs using March 2026 organisational mappings (as referenced by NHS England). ICBs created or reorganised after this date may not be correctly reflected until NHS England updates the extract.
- The 28-day FDS referral volume is used as the demand proxy because it is the most upstream measure available in the monthly ICB extract. It may differ from the total diagnostic referral volume if some pathways fall outside the FDS scope.
- Figures with fewer than 5 patients are suppressed by NHS England for disclosure risk. Where all sub-location rows for a pathway are suppressed, that pathway will show 0/0 and is excluded from ICB totals.
- The GCPPI is not a measure of cancer outcomes or clinical quality — it measures pathway timeliness pressure against a single administrative standard. It should not be used as the sole basis for clinical decisions.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Source data: Cancer Waiting Times CRS Database, NHS England.